Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3601-3605

  Tomita, Masaki ^a   Matsuzaki, Yasunori ^a   Shimizu, Tetsuya ^a   Hara, Masaki ^a   Ayabe, Takanori ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Carcinoembryonic antigen; Lung cancer; pN1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LUNG HILUS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 23344450338     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mountain CF: Revisions in the international system for staging lung. Chest 111: 1710, 1997.
2. Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A and Chehab A: Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 67: 1572-1576, 1999.
3. Tanaka F, Yanagihara K, Otake Y, Yamada T, Shoji T, Miyahara R, Inui K and Wada H: Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 19: 555-561, 2001.
4. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D and Stamatis G: Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 125: 543-553, 2003.
5. Luzzi L, Voltolini L, Campione A, Paladini P, Ghiribelli C, Di Bisceglie M and Gotti G: Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? J Cardiovasc Surg (Torino) 44: 119-123, 2003.
6. Sayar A, Turna A, Kilicgun A, Solak O, Urer N and Gurses A: Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 25: 434-438, 2004.
7. Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M and Sartori F: Prognostic significance of main bronchial lymph node involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer 45: 215-220, 2004.
8. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y and Yasumoto K: Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43: 151-157, 2004.
9. Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM and Luketich JD: Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: A pilot study. J Thorac Cardiovasc Surg 127: 87-91, 2004.
10. Vincent RG, Chu TM, Fergen TB and Ostrander M: Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer 36: 2069-2076, 1975.
11. Concannon JP, Dalbow MH, Hodgson SE, Headings JJ, Markopoulos E, Mitchell J, Cushing WJ and Liebler GA: Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 42: 1477-1483, 1978.
12. Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhead W and Dunnett CW: Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer 42: 1484-1491, 1978.
13. Stokes TC, Stevens JFS, Long P, Lockey E and Miller AL: Preoperative carcinoembryonic antigen and survival after resection of lung cancer. Br J Dis Chest 74: 390-394, 1980.
14. Ford CHJ, Stokes HJ and Newman CE: Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer 44: 145-153, 1981.
15. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P and Levasseur P: Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 55: 811-814, 1994.
16. Rubins JB, Dunitz J, Rubins HB, Maddaus MA and Niewoehner DE: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116: 412-416, 1998.
17. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H and Maeda H: Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 74: 174-179, 2002.
18. Muley T, Dienemann H and Ebert W: Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Anticancer Res 23: 4085-4093, 2003.
19. Gaspar MJ, Diez M, Rodriguez A, Ratia T, Martin Duce A, Galvan M, Granell J and Coca C: Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Anticancer Res 23: 3427-3432, 2003.
20. Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M and Onitsuka T: Prognostic significance of preoperative serum carcinoembrryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 10: 76-80, 2004.
21. Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T and Ito M: Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA non small cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer 101: 803-809, 2004.
22. Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M and Itoh T: Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 25: 520-522, 2004.
23. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A and Tsubota N: Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78: 216-221, 2004.
24. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K and Ichinose Y: Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 107: 1398-1402, 1994.
25. Yoshino I, Nakanishi R, Osaki T, Takenoyama M, Taga S, Hanagiri T and Yasumoto K: Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 116: 144-149, 1999.
26. Alexander JC, Silverman NA and Chretien PB: Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 235: 1975-1979, 1976.
27. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB Jr, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ and Bunn PA Jr: Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 119: 429-439, 2000.